Translational repression & Aspergillus fumigatus virulence

转化抑制

基本信息

  • 批准号:
    8681609
  • 负责人:
  • 金额:
    $ 22.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infections with the opportunistic mold Aspergillus fumigatus continue to be a major threat to the management of patients with hematologic malignancies and organ transplants. Since current antifungal therapies are unable to prevent a high rate of mortality for this disease, there is a need for more information on fungal pathways that allow this organism to thrive in the host environment. Recent studies have shown that A. fumigatus, and other pathogenic fungi, rely heavily on the unfolded protein response (UPR) for infection. The UPR is an adaptive response to endoplasmic reticulum (ER) stress, responsible for adjusting the protein folding capacity of the ER in proportion to the demand placed on the secretory pathway. In mammals, an important branch of the UPR is translational repression mediated by eIF2¿ phosphorylation, a pathway that lowers the influx of nascent proteins into the ER when the organelle is overloaded. Our preliminary data demonstrate that an analogous pathway is present in A. fumigatus, which challenges the existing paradigm of fungal UPR signaling. The overarching hypothesis to be tested in this proposal is that translational repression is a vital stress response of A. fumigatus that contributes to the virulence and antifungal drug susceptibility of this organism. The first aim will use mutants of the pathway to determine the impact of eIF2¿ phosphorylation and translational repression on the ability of the fungus to cause infection and to withstand antifungal drugs and other types of stress. Secondly, an important characteristic of the mammalian pathway is that a limited subset of mRNAs with key functions in ER homeostasis can escape translational repression. Thus, a second aim will use RNA-seq and polysome fractionation to identify mRNAs that show increased translation during ER stress. The outcome of this study is expected to uncover a new paradigm for the fungal ER stress response, which could lead to the development of novel strategies to combat infections with A. fumigatus, and potentially other eukaryotic pathogens that exploit the UPR for virulence.
描述(由适用提供):机会性霉菌曲霉的感染仍然是对血液学恶性肿瘤和器官移植患者管理的主要威胁。由于目前的抗真菌疗法无法预防这种疾病的高死亡率,因此需要更多有关真菌途径的信息,以使该生物可以在宿主环境中蓬勃发展。最近的研究表明,Fumigatus和其他致病真菌在很大程度上依赖于展开的蛋白质反应(UPR)进行感染。 UPR是对内质网(ER)应力的自适应反应,负责调整ER的蛋白质折叠能力,这与秘密途径上的需求成比例。在哺乳动物中,将UPR的重要分支翻译为EIF2¿磷酸化介导的表示,这是一种途径,该途径降低了当细胞器过载时,降低了新生蛋白到ER的影响。我们的初步数据表明,烟曲霉中存在类似的途径,这挑战了真菌UPR信号的现有范式。在该提案中要检验的总体假设是,翻译表达是烟曲霉的重要应激反应,有助于该生物的病毒和抗真菌药物的敏感性。第一个目的将使用途径的突变体来确定EIF2磷酸化和翻译表达对真菌引起感染和承受抗真菌药物和其他类型压力的能力的影响。其次,哺乳动物途径的一个重要特征是,在ER稳态中具有关键功能的mRNA子集有限的子集可以逃避翻译表达。这是第二个目标将使用RNA-seq和多质体分馏来识别在ER应力期间的翻译增加的mRNA。这项研究的结果有望发现真菌ER应激反应的新范式,这可能导致开发新的策略,以用烟曲霉对抗感染,以及可能将UPR剥削为病毒的其他真核生物病原体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID S ASKEW其他文献

DAVID S ASKEW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID S ASKEW', 18)}}的其他基金

Aspergillus fumigatus infection and fibrosis
烟曲霉感染和纤维化
  • 批准号:
    10367232
  • 财政年份:
    2021
  • 资助金额:
    $ 22.31万
  • 项目类别:
Aspergillus fumigatus infection and fibrosis
烟曲霉感染和纤维化
  • 批准号:
    10685373
  • 财政年份:
    2021
  • 资助金额:
    $ 22.31万
  • 项目类别:
ER stress and calcium in host adaptation of A. fumigatus
烟曲霉宿主适应中的内质网应激和钙
  • 批准号:
    9761966
  • 财政年份:
    2016
  • 资助金额:
    $ 22.31万
  • 项目类别:
ER stress and calcium in host adaptation of A. fumigatus
烟曲霉宿主适应中的内质网应激和钙
  • 批准号:
    9979741
  • 财政年份:
    2016
  • 资助金额:
    $ 22.31万
  • 项目类别:
Translational repression & Aspergillus fumigatus virulence
转化抑制
  • 批准号:
    8792613
  • 财政年份:
    2014
  • 资助金额:
    $ 22.31万
  • 项目类别:
High-density lipoprotein and A. fumigatus pathogenesis
高密度脂蛋白与烟曲霉发病机制
  • 批准号:
    8709034
  • 财政年份:
    2013
  • 资助金额:
    $ 22.31万
  • 项目类别:
Translation state array analysis in Aspergillus fumigatus
烟曲霉翻译态阵列分析
  • 批准号:
    7561654
  • 财政年份:
    2008
  • 资助金额:
    $ 22.31万
  • 项目类别:
Translation state array analysis in Aspergillus fumigatus
烟曲霉翻译态阵列分析
  • 批准号:
    7470253
  • 财政年份:
    2008
  • 资助金额:
    $ 22.31万
  • 项目类别:
ER stress and virulence of Aspergillus fumigatus
烟曲霉的内质网应激和毒力
  • 批准号:
    7367672
  • 财政年份:
    2007
  • 资助金额:
    $ 22.31万
  • 项目类别:
ER stress and virulence of Aspergillus fumigatus
烟曲霉的内质网应激和毒力
  • 批准号:
    7739483
  • 财政年份:
    2007
  • 资助金额:
    $ 22.31万
  • 项目类别:

相似海外基金

The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
SARS-CoV-2 免疫失调对抗真菌免疫的影响
  • 批准号:
    10658355
  • 财政年份:
    2023
  • 资助金额:
    $ 22.31万
  • 项目类别:
Development of M-Drive: A recyclable Mucor-optimized CAS9 gene-drive system cable of multi-target gene editing
开发M-Drive:可回收的多靶点基因编辑的毛霉优化CAS9基因驱动系统电缆
  • 批准号:
    10727359
  • 财政年份:
    2023
  • 资助金额:
    $ 22.31万
  • 项目类别:
Antifungals targeting pantothenate phosphorylation
靶向泛酸磷酸化的抗真菌药
  • 批准号:
    10696567
  • 财政年份:
    2023
  • 资助金额:
    $ 22.31万
  • 项目类别:
Lymph node stromal cells coordinate immune cell environments during Aspergillus fumigatus infection
烟曲霉感染期间淋巴结基质细胞协调免疫细胞环境
  • 批准号:
    10751936
  • 财政年份:
    2023
  • 资助金额:
    $ 22.31万
  • 项目类别:
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
开发一种针对糖基磷脂酰肌醇 (GPI) 生物合成和细胞壁生物合成的新型广谱抗真菌治疗药物
  • 批准号:
    10759723
  • 财政年份:
    2023
  • 资助金额:
    $ 22.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了